Reaction went viral when the team released in March its Baysox Oyster Catchers alternate logo that some fans said resembled intimate body parts. Needless to say, the team is moving on, but not ...

SAN DIEGO--(BUSINESS WIRE)--Candid Therapeutics, Inc. (“Candid”), a clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel T-cell ...

MILPITAS, Calif. , June 18, 2025 /PRNewswire/ -- Galaxy Therapeutics, a privately held, clinical-stage medical device company focused on treating brain aneurysms, today announced that Dr. Michael ...

CRISPR Therapeutics’ CRSP first marketed product is the one-shot gene therapy Casgevy, approved in late 2023 and early 2024 across the United States and Europe for two blood disorder indications ...

Galaxy Therapeutics Appoints Neurovascular Industry Expert, Dr. Michael Alexander, as Chief Medical Officer Provided by PR Newswire Jun 19, 2025, 4:06:00 AM ...

Galaxy Therapeutics Appoints Neurovascular Industry Expert, Dr. Michael Alexander, as Chief Medical Officer By Galaxy Therapeutics Jun 19, 2025 Updated Jun 19, 2025 Galaxy Therapeutics Logo ...

Regulatory News: PHAXIAM Therapeutics (Euronext: PHXM - FR001400K4B1), hereinafter referred to as “the Company” or “PHAXIAM,” a biopharmaceutical company spe ...

Eli Lilly (LLY) is reportedly nearing a deal to acquire gene editing startup Verve Therapeutics (VERV) for up to $1.3 billion, the Financial Times reported.